Free Trial
NYSE:HIMS

Hims & Hers Health (HIMS) Stock Price, News & Analysis

Hims & Hers Health logo
$20.64
-0.12 (-0.58%)
(As of 11/5/2024 ET)

About Hims & Hers Health Stock (NYSE:HIMS)

Key Stats

Today's Range
$19.54
$22.28
50-Day Range
$13.65
$23.59
52-Week Range
$6.23
$25.74
Volume
41.68 million shs
Average Volume
8.49 million shs
Market Capitalization
$4.43 billion
P/E Ratio
258.03
Dividend Yield
N/A
Price Target
$20.50
Consensus Rating
Moderate Buy

Company Overview

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
60th Percentile Overall Score

HIMS MarketRank™: 

Hims & Hers Health scored higher than 60% of companies evaluated by MarketBeat, and ranked 711th out of 969 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hims & Hers Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 8 buy ratings, 8 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Hims & Hers Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Hims & Hers Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Hims & Hers Health are expected to grow by 68.18% in the coming year, from $0.22 to $0.37 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hims & Hers Health is 258.03, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 130.17.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hims & Hers Health is 258.03, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 106.46.

  • Price to Book Value per Share Ratio

    Hims & Hers Health has a P/B Ratio of 12.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Hims & Hers Health's valuation and earnings.
  • Percentage of Shares Shorted

    18.32% of the float of Hims & Hers Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hims & Hers Health has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hims & Hers Health has recently increased by 28.72%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Hims & Hers Health does not currently pay a dividend.

  • Dividend Growth

    Hims & Hers Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.32% of the float of Hims & Hers Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hims & Hers Health has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hims & Hers Health has recently increased by 28.72%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Hims & Hers Health has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 51 news articles for Hims & Hers Health this week, compared to 13 articles on an average week.
  • Search Interest

    68 people have searched for HIMS on MarketBeat in the last 30 days. This is an increase of 19% compared to the previous 30 days.
  • MarketBeat Follows

    41 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 242% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,148,890.00 in company stock.

  • Percentage Held by Insiders

    17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Hims & Hers Health's insider trading history.
Receive HIMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter.

HIMS Stock News Headlines

Stocks buyng
Top 3 Stocks Institutions Are Buying Right Now (HIMS)
Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks.
This is treason
If you missed it, my emergency election broadcast is now available - but will be removed soon
See More Headlines

HIMS Stock Analysis - Frequently Asked Questions

Hims & Hers Health's stock was trading at $8.90 at the start of the year. Since then, HIMS stock has increased by 131.9% and is now trading at $20.64.
View the best growth stocks for 2024 here
.

Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings data on Monday, November, 4th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.26. Hims & Hers Health's revenue for the quarter was up 77.1% compared to the same quarter last year.

Hims & Hers Health's top institutional investors include IMC Chicago LLC, Carnegie Investment Counsel (0.14%), Principal Financial Group Inc. (0.14%) and QRG Capital Management Inc. (0.08%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Michael Chi, Patrick Harrison Carroll, Soleil Boughton, Oluyemi Okupe, Jules A Maltz, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Lynne Chou O'keefe and Jack Abraham.
View institutional ownership trends
.

Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Palantir Technologies (PLTR), Netflix (NFLX) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
11/04/2024
Today
11/05/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/24/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
Healthcare
Fax
N/A
Employees
1,046
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.71
High Stock Price Target
$28.00
Low Stock Price Target
$10.00
Potential Upside/Downside
-3.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
16 Analysts

Profitability

Net Income
$-23,550,000.00
Pretax Margin
1.98%

Debt

Sales & Book Value

Annual Sales
$872 million
Book Value
$1.61 per share

Miscellaneous

Free Float
176,747,000
Market Cap
$4.56 billion
Optionable
Optionable
Beta
1.06
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (NYSE:HIMS) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners